Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (1-10 of 280) with videos related to

Pageof 28
Sort By:
The Lancet. Haematology|December 24, 2022
A new player in IDH1 mutated myeloid neoplasiasMichael Heuser
Hematology. American Society of Hematology. Education Program|December 4, 2016
Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?Michael Heuser
Hematology. American Society of Hematology. Education Program|December 7, 2024
Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patientMichael Heuser, Rabia Shahswar
Innere Medizin (Heidelberg, Germany)|September 19, 2022
[Diagnostics in unclear cytopenia-How and when do we screen for clonal hematopoiesis?]Claudia Haferlach, Michael Heuser
Expert Opinion on Therapeutic Targets|April 26, 2019
Emerging strategies to target the dysfunctional cohesin complex in cancerKonstantinos Mintzas, Michael Heuser
Journal of Sports Sciences|April 15, 2010
The effects of stretching on knee flexor fatigue and perceived exertionMichael Heuser, Danny Pincivero
Expert Opinion on Therapeutic Targets|December 14, 2017
Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancerNidhi Jyotsana, Michael Heuser
Cancers|December 24, 2021
Mouse Models of Frequently Mutated Genes in Acute Myeloid LeukemiaSagarajit Mohanty, Michael Heuser
Annals of Hematology|July 28, 2005
Colony-stimulating factors in the management of neutropenia and its complicationsMichael Heuser, Arnold Ganser
Current Opinion in Hematology|December 9, 2016
Therapy-related myeloid neoplasmsArnold Ganser, Michael Heuser
Pageof 28

Showing results (1-10 of 280) with videos related to

Sort By:
Pageof 28
The Lancet. Haematology|December 24, 2022
A new player in IDH1 mutated myeloid neoplasiasMichael Heuser
Hematology. American Society of Hematology. Education Program|December 4, 2016
Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?Michael Heuser
Hematology. American Society of Hematology. Education Program|December 7, 2024
Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patientMichael Heuser, Rabia Shahswar
Innere Medizin (Heidelberg, Germany)|September 19, 2022
[Diagnostics in unclear cytopenia-How and when do we screen for clonal hematopoiesis?]Claudia Haferlach, Michael Heuser
Expert Opinion on Therapeutic Targets|April 26, 2019
Emerging strategies to target the dysfunctional cohesin complex in cancerKonstantinos Mintzas, Michael Heuser
Journal of Sports Sciences|April 15, 2010
The effects of stretching on knee flexor fatigue and perceived exertionMichael Heuser, Danny Pincivero
Expert Opinion on Therapeutic Targets|December 14, 2017
Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancerNidhi Jyotsana, Michael Heuser
Cancers|December 24, 2021
Mouse Models of Frequently Mutated Genes in Acute Myeloid LeukemiaSagarajit Mohanty, Michael Heuser
Annals of Hematology|July 28, 2005
Colony-stimulating factors in the management of neutropenia and its complicationsMichael Heuser, Arnold Ganser
Current Opinion in Hematology|December 9, 2016
Therapy-related myeloid neoplasmsArnold Ganser, Michael Heuser
Pageof 28